Page last updated: 2024-09-04

cv 159 and Atherogenesis

cv 159 has been researched along with Atherogenesis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hara, Y; Kamibayashi, M; Okada, M; Usui, T; Yamawaki, H	1

Other Studies

1 other study(ies) available for cv 159 and Atherogenesis

Article	Year
CV-159, a unique dihydropyridine derivative, prevents TNF-induced inflammatory responses in human umbilical vein endothelial cells. Journal of pharmacological sciences, 2010, Volume: 113, Issue:2 Topics: Atherosclerosis; Calcium Channel Blockers; Cells, Cultured; Depression, Chemical; Dihydropyridines; E-Selectin; Endothelial Cells; Female; Humans; JNK Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Reactive Oxygen Species; Transcription Factor RelA; Tumor Necrosis Factor-alpha; Umbilical Veins	2010

Article

Year

CV-159, a unique dihydropyridine derivative, prevents TNF-induced inflammatory responses in human umbilical vein endothelial cells.

Journal of pharmacological sciences, 2010, Volume: 113, Issue:2

Topics: Atherosclerosis; Calcium Channel Blockers; Cells, Cultured; Depression, Chemical; Dihydropyridines; E-Selectin; Endothelial Cells; Female; Humans; JNK Mitogen-Activated Protein Kinases; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Reactive Oxygen Species; Transcription Factor RelA; Tumor Necrosis Factor-alpha; Umbilical Veins

2010